American Academy of Ophthalmology Meeting

A study found patients requiring emergency ophthalmic care during COVID-19 stay-at-home orders were less likely to have health insurance, more likely to delay seeking treatment and traveled farther for care, according to a presentation.

An automated direct transscleral selective laser trabeculoplasty device demonstrated safety and efficacy in a first-in-human study, Michal Belkin, MD, said in a presentation at the virtual American Academy of Ophthalmology annual meeting.

Re-bubbling a Descemet’s membrane endothelial keratoplasty graft using an in-office slit lamp may be safer than using a surgical scope, according to a presentation at the virtual American Academy of Ophthalmology annual meeting.

Drive-through IOP checks allow safe management of high-risk glaucoma patients during the SARS-CoV-2 pandemic, according to a poster presented at the virtual American Academy of Ophthalmology annual meeting.

Orbital fractures from firearms are more likely to cause severe vision loss in the presence of concurrent intraocular injuries, according to a presentation at the virtual American Academy of Ophthalmology annual meeting.

In this video, Caroline R. Baumal, MD, professor at Tufts University School of Medicine, discusses topics in age-related macular degeneration from the virtual American Academy of Ophthalmology annual meeting and her hopes for 2021.

Most patients in the IRIS Registry and Komodo Database who initiated brolucizumab previously used another form of anti-VEGF treatment, according to research presented at the virtual American Academy of Ophthalmology annual meeting.

Artificial intelligence-based telemedicine platform may allow for large-scale screening of patients with age-related macular degeneration while lowering the cost of care, according to a poster at AAO Annual Meeting.

In this video, Caroline R. Baumal, MD, professor at Tufts University School of Medicine, highlighted data from an IRIS study presented at the virtual American Academy of Ophthalmology annual meeting.

Vision outcomes using a port delivery system proved equivalent to ranibizumab injections and showed a positive benefit profile, according to data presented at the virtual American Academy of Ophthalmology annual meeting.